14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ANTH
Delisted

Anthera Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Jan 14, 2019 $0.0680 $0.0680 $0.0620 $0.0640 88 895
Jan 11, 2019 $0.0697 $0.0700 $0.0620 $0.0696 21 979
Jan 10, 2019 $0.0600 $0.0700 $0.0600 $0.0700 103 482
Jan 09, 2019 $0.0600 $0.0700 $0.0450 $0.0700 196 899
Jan 08, 2019 $0.0735 $0.0749 $0.0450 $0.0570 37 420
Jan 07, 2019 $0.0400 $0.0500 $0.0311 $0.0500 375 347
Jan 04, 2019 $0.0370 $0.0370 $0.0310 $0.0367 49 577
Jan 03, 2019 $0.0439 $0.0439 $0.0300 $0.0363 43 576
Jan 02, 2019 $0.0250 $0.0433 $0.0250 $0.0433 8 779
Dec 31, 2018 $0.0330 $0.0450 $0.0230 $0.0260 322 640
Dec 28, 2018 $0.0345 $0.0403 $0.0335 $0.0338 268 690
Dec 27, 2018 $0.0360 $0.0450 $0.0360 $0.0360 256 369
Dec 26, 2018 $0.0345 $0.0460 $0.0345 $0.0406 183 222
Dec 24, 2018 $0.0330 $0.0440 $0.0330 $0.0430 120 497
Dec 21, 2018 $0.0345 $0.0480 $0.0345 $0.0360 43 738
Dec 20, 2018 $0.0330 $0.0445 $0.0300 $0.0345 248 582
Dec 19, 2018 $0.0330 $0.0360 $0.0330 $0.0340 24 010
Dec 18, 2018 $0.0330 $0.0430 $0.0330 $0.0356 126 497
Dec 17, 2018 $0.0309 $0.0400 $0.0309 $0.0360 75 759
Dec 14, 2018 $0.0330 $0.0450 $0.0330 $0.0340 95 578
Dec 13, 2018 $0.0314 $0.0450 $0.0314 $0.0450 22 029
Dec 12, 2018 $0.0450 $0.0500 $0.0300 $0.0375 89 899
Dec 11, 2018 $0.0410 $0.0500 $0.0410 $0.0450 50 597
Dec 10, 2018 $0.0400 $0.0500 $0.0400 $0.0450 74 414
Dec 07, 2018 $0.0380 $0.0590 $0.0350 $0.0374 47 859
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT